Capricor Therapeutics (CAPR)_個股概要_股票價格_行情走勢圖

5.010
-0.040-0.79%

收盤價 04/19 16:00 (美東)

5.080
+0.070+1.40%

盤後 18:01 (美東)

1.58億總市值-6036市盈率TTM

代碼股票名稱

最新價漲跌額漲跌幅成交量成交額今開昨收最高最低總市值流通市值總股本流通股本5日漲跌幅10日漲跌幅20日漲跌幅60日漲跌幅120日漲跌幅250日漲跌幅年初至今漲跌幅股息率TTM換手率市盈率TTM市盈率(靜)振幅所屬行業

評論

Trytosaveabit

02/27 21:34

Update

$Capricor Therapeutics(CAPR.US)$ Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy
4 MINUTES AGO, 8:30 AM EST
VIA GLOBENEWSWIRE

GainorsOnHammers

02/24 01:30

$Capricor Therapeutics(CAPR.US)$ we'll. see $5.34 soon.

Moomoo AI

02/03 20:28

Investors' expectations of limited future growth may be causing the low P/S ratio. These conditions form a barrier for the share price unless improved. Consider other vital risk factors before investing in Capricor Therapeutics.

Revenues Working Against Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Share Price Following 25% Dive

Trytosaveabit

01/11 22:08

Update

$Capricor Therapeutics(CAPR.US)$Moomoo 24/7· just. Capricor Therapeutics Receives First Milestone Payment Of $10M From Nippon Shinyaku, Co. Under Exclusive Commercialization And Distribution Agreement

Moomoo AI

2023/12/13 03:10

Capricor Therapeutics is anticipated to see limited growth in the future, keeping its P/S ratio low. Despite recent growth, its muted future outlook compared to the overall industry could remain a barrier for its share price.

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Surges 29% Yet Its Low P/S Is No Reason For Excitement

CAPR Capricor Therapeutics

資金分布

資金流向

新聞

評論

Update

Update

分析

分析師評級

目標價預測